Pretreatment assessment of hepatocellular cancer: expert consensus conference
- PMID: 20590902
- PMCID: PMC2951815
- DOI: 10.1111/j.1477-2574.2010.00187.x
Pretreatment assessment of hepatocellular cancer: expert consensus conference
Comment on
-
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.HPB (Oxford). 2010 Jun;12(5):289-99. doi: 10.1111/j.1477-2574.2010.00181.x. HPB (Oxford). 2010. PMID: 20590901 Free PMC article.
Similar articles
-
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.HPB (Oxford). 2010 Jun;12(5):289-99. doi: 10.1111/j.1477-2574.2010.00181.x. HPB (Oxford). 2010. PMID: 20590901 Free PMC article.
-
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus conference.HPB (Oxford). 2010 Jun;12(5):321-2. doi: 10.1111/j.1477-2574.2010.00186.x. HPB (Oxford). 2010. PMID: 20590906 Free PMC article. No abstract available.
-
Surgical treatment of hepatocellular cancer: expert consensus conference.HPB (Oxford). 2010 Jun;12(5):311-2. doi: 10.1111/j.1477-2574.2010.00188.x. HPB (Oxford). 2010. PMID: 20590904 Free PMC article. No abstract available.
-
Imaging diagnosis and staging of hepatocellular carcinoma.Liver Transpl. 2011 Oct;17 Suppl 2:S34-43. doi: 10.1002/lt.22369. Liver Transpl. 2011. PMID: 21739567 Review. No abstract available.
-
AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma.HPB (Oxford). 2010 Jun;12(5):287-8. doi: 10.1111/j.1477-2574.2010.00184.x. HPB (Oxford). 2010. PMID: 20590900 Free PMC article. No abstract available.
Cited by
-
Liver Stiffness Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in Patients with Hepatocellular Carcinoma.J Gastrointest Surg. 2017 Sep;21(9):1471-1479. doi: 10.1007/s11605-017-3443-9. Epub 2017 May 16. J Gastrointest Surg. 2017. PMID: 28510795
-
Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma.J Hepatocell Carcinoma. 2015 Sep 18;2:131-42. doi: 10.2147/JHC.S81309. eCollection 2015. J Hepatocell Carcinoma. 2015. PMID: 27508202 Free PMC article. Review.
-
Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.J Natl Cancer Inst. 2014 May 9;106(5):dju088. doi: 10.1093/jnci/dju088. J Natl Cancer Inst. 2014. PMID: 24815863 Free PMC article.
-
Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.J Clin Oncol. 2011 Oct 10;29(29):3892-9. doi: 10.1200/JCO.2011.36.0636. Epub 2011 Sep 12. J Clin Oncol. 2011. PMID: 21911725 Free PMC article.
-
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib.Oncotarget. 2021 Apr 13;12(8):756-766. doi: 10.18632/oncotarget.27924. eCollection 2021 Apr 13. Oncotarget. 2021. PMID: 33889299 Free PMC article.
References
-
- Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236. - PubMed
-
- Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology. 2007;244:898–906. - PubMed
-
- Nicolau C, Catala V, Vilana R, Gilabert R, Bianchi L, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol. 2004;14:1092–1099. - PubMed
-
- Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–1181. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical